Preoperative iron supplementation and intraoperative transfusion during colorectal cancer surgery

Surg Today. 2005;35(1):36-40. doi: 10.1007/s00595-004-2888-0.

Abstract

Purpose: To investigative whether giving an iron preparation to anemic patients before colorectal cancer surgery improves their anemia and reduces the need for intraoperative blood transfusion.

Methods: Among 569 patients who underwent colorectal cancer surgery between 1998 and 2003, we studied 32 anemic patients who received iron supplementation for at least 2 weeks preoperatively (group A) and 84 anemic patients who did not (group B). Anemia was defined as a hemoglobin (Hb) level at first presentation of </=10.0 g/dl. Hemoglobin and hematocrit (Ht) levels were measured at first presentation, then immediately before and after surgery. We also calculated intraoperative blood loss and compared intraoperative transfusion rates.

Results: There were no significant differences between groups A and B in age, sex, surgical technique, tumor stage, and operating time. Their Hb and Ht values were similar at first presentation, but significantly different immediately before surgery (both P < 0.0001). There were no significant differences in intraoperative blood loss between the groups, but significantly fewer patients in group A needed an intraoperative blood transfusion (9.4% vs 27.4%, P < 0.05).

Conclusion: Iron supplementation for at least 2 weeks before colorectal cancer surgery increases Hb and Ht values in anemic patients, and reduces the need for intraoperative transfusion.

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Anemia, Iron-Deficiency / prevention & control
  • Blood Transfusion, Autologous / methods
  • Blood Transfusion, Autologous / statistics & numerical data*
  • Case-Control Studies
  • Colorectal Neoplasms / mortality*
  • Colorectal Neoplasms / pathology
  • Colorectal Neoplasms / therapy*
  • Colorectal Surgery / methods*
  • Female
  • Humans
  • Intraoperative Care / methods
  • Iron Compounds / therapeutic use*
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Preoperative Care / methods
  • Probability
  • Prognosis
  • Reference Values
  • Retrospective Studies
  • Risk Assessment
  • Survival Analysis
  • Treatment Outcome

Substances

  • Iron Compounds